Milind Deshpande
2011
In 2011, Milind Deshpande earned a total compensation of $1.1M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,536 |
|---|---|
| Option Awards | $555,511 |
| Salary | $359,975 |
| Other | $7,703 |
| Total | $1,067,725 |
Deshpande received $555.5K in option awards, accounting for 52% of the total pay in 2011.
Deshpande also received $144.5K in non-equity incentive plan, $360K in salary and $7.7K in other compensation.
Rankings
In 2011, Milind Deshpande's compensation ranked 5,418th out of 10,747 executives tracked by ExecPay. In other words, Deshpande earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,418 out of 10,747 | 50th |
Division Manufacturing | 1,960 out of 3,958 | 51st |
Major group Chemicals And Allied Products | 427 out of 1,034 | 59th |
Industry group Drugs | 267 out of 782 | 66th |
Industry Pharmaceutical Preparations | 208 out of 567 | 63rd |
Source: SEC filing on April 18, 2014.
Deshpande's colleagues
We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2011.
2011
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2011
Elizabeth Olek
Achillion Pharmaceuticals
Chief Medical Officer
2011
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2011
Gautam Shah
Achillion Pharmaceuticals
Executive Vice President and Chief Compliance Officer
2011
Mary Fenton
Achillion Pharmaceuticals